ChemicalBook > CAS DataBase List > (8R)-8-(3,5-Difluorophenyl)-10-oxo-N-[(2R)-1,1',2',3-tetrahydro-2'-oxospiro[2H-indene-2,3'-[3H]pyrrolo[2,3-b]pyridin]-5-yl]-6,9-diazaspiro[4.5]decane-9-acetamide

(8R)-8-(3,5-Difluorophenyl)-10-oxo-N-[(2R)-1,1',2',3-tetrahydro-2'-oxospiro[2H-indene-2,3'-[3H]pyrrolo[2,3-b]pyridin]-5-yl]-6,9-diazaspiro[4.5]decane-9-acetamide

Product Name
(8R)-8-(3,5-Difluorophenyl)-10-oxo-N-[(2R)-1,1',2',3-tetrahydro-2'-oxospiro[2H-indene-2,3'-[3H]pyrrolo[2,3-b]pyridin]-5-yl]-6,9-diazaspiro[4.5]decane-9-acetamide
CAS No.
957118-49-9
Chemical Name
(8R)-8-(3,5-Difluorophenyl)-10-oxo-N-[(2R)-1,1',2',3-tetrahydro-2'-oxospiro[2H-indene-2,3'-[3H]pyrrolo[2,3-b]pyridin]-5-yl]-6,9-diazaspiro[4.5]decane-9-acetamide
Synonyms
MK 3207;MK3207; MK 3207;2-((R)-8-(3,5-Difluorophenyl)-10-oxo-6,9-diazaspiro[4.5]decan-9-yl)-N-((R)-2'-oxo-1,1',2',3-tetrahydrospiro[indene-2,3'-pyrrolo[2,3-b]pyridin]-5-yl)acetamide;2-((R)-8-(3,5-Difluorophenyl)-10-oxo-6,9-diazaspiro[4.5]decan-9-yl)-N-((R)-2'-oxo-1,1',2',3-tetrahydrospiro[indene-2,3'-pyrrolo[2,3-b]pyridin]-5-yl)acetamide;(8R)-8-(3,5-Difluorophenyl)-10-oxo-N-[(2R)-1,1',2',3-tetrahydro-2'-oxospiro[2H-indene-2,3'-[3H]pyrrolo[2,3-b]pyridin]-5-yl]-6,9-diazaspiro[4.5]decane-9-acetamide;(8R)-8-(3,5-Difluorophenyl)-10-oxo-N-[(2R)-1,1',2',3-tetrahydro-2'-oxospiro[2H-indene-2,3'-[3H]pyrrolo[2,3-b]pyridin]-5-yl]-6,9-diazaspiro[4.5]decane-9-acetamide;6,9-Diazaspiro[4.5]decane-9-acetaMide,8-(3,5-difluorophenyl)-10-oxo-N-[(2R)-1,1',2',3-tetrahydro-2'-oxospiro[2H-indene-2,3'-[3H]pyrrolo[2,3-b]pyridin]-5-yl]-,(8R)-
CBNumber
CB22510103
Molecular Formula
C31H29F2N5O3
Formula Weight
557.59
MOL File
957118-49-9.mol
More
Less

(8R)-8-(3,5-Difluorophenyl)-10-oxo-N-[(2R)-1,1',2',3-tetrahydro-2'-oxospiro[2H-indene-2,3'-[3H]pyrrolo[2,3-b]pyridin]-5-yl]-6,9-diazaspiro[4.5]decane-9-acetamide Property

Density 
1.45
storage temp. 
Store at -20°C
solubility 
Soluble in DMSO
form 
Powder
color 
White to off-white
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

TRC
Product number
M425005
Product name
MK-3207
Packaging
10mg
Price
$1385
Updated
2021/12/16
Medical Isotopes, Inc.
Product number
41647
Product name
MK-3207
Packaging
50mg
Price
$15500
Updated
2021/12/16
Medical Isotopes, Inc.
Product number
41647
Product name
MK-3207
Packaging
500mg
Price
$23500
Updated
2021/12/16
ChemScene
Product number
CS-1449
Product name
MK-3207
Purity
98.76%
Packaging
5mg
Price
$192
Updated
2021/12/16
ApexBio Technology
Product number
A3615
Product name
MK-3207
Packaging
5mg
Price
$252
Updated
2021/12/16
More
Less

(8R)-8-(3,5-Difluorophenyl)-10-oxo-N-[(2R)-1,1',2',3-tetrahydro-2'-oxospiro[2H-indene-2,3'-[3H]pyrrolo[2,3-b]pyridin]-5-yl]-6,9-diazaspiro[4.5]decane-9-acetamide Chemical Properties,Usage,Production

Uses

MK-3207 is a potent and orally active calcitonin gene-related peptide (CGRP) receptor antagonist used for the treatment of migraine.

Biological Activity

mk-3207 is a new, highly selective cgrp receptor antagonist that is approximately 40- to 65-fold more potent than telcagepant for the human cgrp receptor. the ic50 is 0.12 nm and the ki value is 0.024 nm. it is highly selective versus human am1, am2, ctr, and amy3. [1]calcitonin gene-related peptide (cgrp) is a 37 amino acid neuropeptide that is widely distributed in the central and peripheral nervous system. the cgrp receptor is composed of the calcitonin receptor-like receptor (clr), a family b g protein-coupled receptor (gpcr), in association with receptor activity modifying protein 1 (ramp1) and receptor component protein. a number of lines of evidence implicated cgrp in migraine pathophysiology, and this led to interest in the potential utility of cgrp receptor antagonists as novel therapeutics for migraine. [2]mk-3207 displayed high affinity for the native human cgrp receptor in sk-n-mc cells and for the recombinant human receptor as measured by the ability to compete with 125i-hcgrp binding, with ki values of 0.024 ± 0.001 nm and 0.022 ± 0.002 nm, respectively. mk-3207 displayed a similar affinity (ki) for the rhesus monkey receptor (0.024 ± 0.001 nm) as for human, but it displayed 400-fold lower affinity for the canine and rat receptors, with values of 10 nm and 10 ± 1.2 nm , respectively. mk-3207 potently blocked human α-cgrp-stimulated camp responses in human cgrp receptor-expressing hek293 cells, with an ic50 value of 0.12 ±0.02 nm . addition of 50% human serum (ic50 =0.17 ± 0.02nm) had little effect on the apparent potency ofmk-3207. [3]mk-3207 has ec50 and emax values of approximately 0.8 ± 0.3 nm (mean ± s.e.) and 81 ± 5% (mean ± s.e.), respectively, for inhibition of cidv in rhesus monkeys. the expected ec90 value in rhesus monkey is therefore approximately 7 nm (9-fold higher than the estimated ec50 value). after an oral dose of 10 mg/kg mk-3207, the csf/plasma ratio is 2 to 3% . however, the csf/ plasma ratio is approximately 30% of the unbound fraction (9.4%) in plasma, indicating that the central and peripheral compartments are not freely equilibrating.

target

CGRP

References

[1] david j hewitt, sheena k aurora, david w dodick et al. randomized controlled trial of the cgrp receptor antagonist mk-3207 in the acute treatment of migraine. cephalalgia 31(6) 712–722.
[2] ian m. bell, steven n. gallicchio, michael r. wood et al. discovery of mk-3207: a highly potent, orally bioavailable cgrp receptor antagonist. acs med. chem. lett. 2010, 1, 24–29.
[3] christopher a. salvatore, eric l. moore, amy calamari, jacquelynn j. cook, et al. pharmacological properties of mk-3207, a potent and orally active calcitonin gene-related peptide receptor antagonist. doi:10.1124/jpet.109.163816.

(8R)-8-(3,5-Difluorophenyl)-10-oxo-N-[(2R)-1,1',2',3-tetrahydro-2'-oxospiro[2H-indene-2,3'-[3H]pyrrolo[2,3-b]pyridin]-5-yl]-6,9-diazaspiro[4.5]decane-9-acetamide Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

(8R)-8-(3,5-Difluorophenyl)-10-oxo-N-[(2R)-1,1',2',3-tetrahydro-2'-oxospiro[2H-indene-2,3'-[3H]pyrrolo[2,3-b]pyridin]-5-yl]-6,9-diazaspiro[4.5]decane-9-acetamide Suppliers

Chembest Research Laboratories Limited
Tel
+86-21-20908456
Fax
021-58180499
Email
sales@BioChemBest.com
Country
China
ProdList
6008
Advantage
61
T&W GROUP
Tel
021-61551611 13296011611
Fax
+86 21-50676805
Email
contact@trustwe.com
Country
China
ProdList
9900
Advantage
58
NCE Biomedical Co.,Ltd.
Tel
4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988
Fax
+86-27-87599188
Country
China
ProdList
1494
Advantage
55
Shanghai T&W Pharmaceutical Co., Ltd.
Tel
+86 21 61551611
Fax
+86 21 50676805
Country
China
ProdList
9900
Advantage
58
Haoyuan Chemexpress Co., Ltd.
Tel
021-58950125
Fax
(86) 21-58955996
Email
info@chemexpress.com
Country
China
ProdList
7553
Advantage
61
Jinan Mingya Medical Technology Co., Ltd.
Tel
0531-85828981
Fax
+86-531-85806006
Email
864598798@qq.com
Country
China
ProdList
588
Advantage
58
SPIRO PHARMA
Tel
Fax
-
Email
eric_feng1954@126.com
Country
China
ProdList
9254
Advantage
55
Codow Chemical Co.,Ltd.
Tel
18620099427
Fax
+86-20-62619665
Email
amy@howeipharm.com
Country
China
ProdList
17698
Advantage
55
Chengdu Dianchun Technology Co., Ltd
Tel
400-1166-196 18502815961
Fax
QQ:800101999
Email
cdhxsj@163.com
Country
China
ProdList
14623
Advantage
60
Musechem
Tel
+1-800-259-7612
Fax
+1-800-259-7612
Email
info@musechem.com
Country
United States
ProdList
4662
Advantage
60

957118-49-9, (8R)-8-(3,5-Difluorophenyl)-10-oxo-N-[(2R)-1,1',2',3-tetrahydro-2'-oxospiro[2H-indene-2,3'-[3H]pyrrolo[2,3-b]pyridin]-5-yl]-6,9-diazaspiro[4.5]decane-9-acetamideRelated Search:


  • MK 3207
  • (8R)-8-(3,5-Difluorophenyl)-10-oxo-N-[(2R)-1,1',2',3-tetrahydro-2'-oxospiro[2H-indene-2,3'-[3H]pyrrolo[2,3-b]pyridin]-5-yl]-6,9-diazaspiro[4.5]decane-9-acetamide
  • 6,9-Diazaspiro[4.5]decane-9-acetaMide,8-(3,5-difluorophenyl)-10-oxo-N-[(2R)-1,1',2',3-tetrahydro-2'-oxospiro[2H-indene-2,3'-[3H]pyrrolo[2,3-b]pyridin]-5-yl]-,(8R)-
  • MK3207; MK 3207
  • 2-((R)-8-(3,5-Difluorophenyl)-10-oxo-6,9-diazaspiro[4.5]decan-9-yl)-N-((R)-2'-oxo-1,1',2',3-tetrahydrospiro[indene-2,3'-pyrrolo[2,3-b]pyridin]-5-yl)acetamide
  • 2-((R)-8-(3,5-Difluorophenyl)-10-oxo-6,9-diazaspiro[4.5]decan-9-yl)-N-((R)-2'-oxo-1,1',2',3-tetrahydrospiro[indene-2,3'-pyrrolo[2,3-b]pyridin]-5-yl)acetamide
  • (8R)-8-(3,5-Difluorophenyl)-10-oxo-N-[(2R)-1,1',2',3-tetrahydro-2'-oxospiro[2H-indene-2,3'-[3H]pyrrolo[2,3-b]pyridin]-5-yl]-6,9-diazaspiro[4.5]decane-9-acetamide
  • 957118-49-9
  • C31H29F2N5O3